
Clopiriv 75mg Tablet
Marketer
East African (India) Overseas
Salt Composition
Clopidogrel (75mg)
Overview Clopiriv 75mg Tablet
CardioGuard 75mg tablets are antithrombotic agents, preventing the formation of dangerous blood clots within your circulatory system. This reduces your risk of stroke and heart attack, making it a common heart-protective medication. CardioGuard 75mg is prescribed for individuals with a heightened risk of cardiovascular events, including those with peripheral artery disease (circulatory issues from narrowed arteries), recent stroke or myocardial infarction, arrhythmias, or post-stenting. It's also used alongside other medications to manage heart attacks and unstable angina. This medication can be taken with or without food, consistently at the same time daily. Continued use is crucial, even during periods of good health, as discontinuation increases the risk of cardiovascular complications. The most prevalent side effect is increased bleeding, manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual bleeding. Wounds may bleed more profusely and longer. While typically mild and self-limiting, persistent or concerning bleeding necessitates immediate medical attention. This medication isn't for everyone. Avoid use if you have active internal bleeding, such as a gastric ulcer or intracranial hemorrhage. Inform your physician of any prior bleeding disorders, recent major injuries, or upcoming surgeries before commencing treatment. Temporary discontinuation may be necessary prior to scheduled procedures or dental work.
Uses of Clopiriv 75mg Tablet
Avoiding heart attacks and strokes
Major Benefits of Clopiriv 75mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Clopiriv 75mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Clopiriv 75mg Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use Clopiriv 75mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; avoid crushing, chewing, or breaking it. Clopiriv 75mg Tablets can be taken with or without food, however, consistent timing is recommended.
How Clopiriv 75mg Tablet works:
Aggrenox 75mg tablets are a medication that inhibits platelet aggregation. By reducing platelet clumping, they diminish the risk of dangerous blood clots, thus lowering the likelihood of a stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Clopiriv 75mg Tablet concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Clopiriv 75mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential benefits against the risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingSAFE IF PRESCRIBED
Administration of Clopiriv 75mg tablets while breastfeeding appears to pose minimal risk. Available human data indicate negligible danger to the infant.
DrivingSAFE
Driving ability is typically unaffected by Clopiriv 75mg Tablets.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Clopiriv 75mg tablets are considered safe, and no dosage modification is necessary.
LiverSAFE IF PRESCRIBED
Clopiriv 75mg tablets may be administered to patients with hepatic impairment without modification to the prescribed dosage.
What if you forget to take Clopiriv 75mg Tablet :
Should you forget to take your Clopiriv 75mg Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Clopiriv 75mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Amino acid alkyl esters |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action class | ADP receptor antagonists (P2Y12 inhibitors) |
